Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Growth Hormone Secretagogue Receptor (GHSR), also known as the ghrelin receptor, is a G protein-coupled receptor that mediates the effects of growth hormone secretagogues, including the endogenous ligand ghrelin. GHSR plays a central role in stimulating growth hormone release, regulating appetite and energy homeostasis, modulating glucose and lipid metabolism, influencing gastrointestinal motility and secretion, protecting neuronal and cardiovascular cells, and regulating immune function. Targeted by drugs aiming to treat conditions like cachexia/anorexia nervosa, cardiovascular diseases, metabolic syndrome, age-related decline in GH/IGF axis, and potentially neurodegenerative disorders. Antagonists/inverse agonists are being explored for obesity treatment due to their ability to suppress appetite.
Agonists bind to GHSR, activating G proteins (primarily Gαq/11), increasing intracellular calcium levels, and stimulating growth hormone secretion. Antagonists/inverse agonists suppress appetite.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth Hormone Secretagogue Receptor (GHS-R).